The landscape of managing diabetes is evolving with the emergence of skin-applied GLP-1 therapy. These convenient delivery systems offer a possibly more comfortable alternative to shots for individuals managing diabetes 2. Such a system deliver glucagon-like peptide-1 directly through the epiderm